ATE218345T1 - Arzneimittel gegen spinocerebellare degeneration - Google Patents

Arzneimittel gegen spinocerebellare degeneration

Info

Publication number
ATE218345T1
ATE218345T1 AT95927966T AT95927966T ATE218345T1 AT E218345 T1 ATE218345 T1 AT E218345T1 AT 95927966 T AT95927966 T AT 95927966T AT 95927966 T AT95927966 T AT 95927966T AT E218345 T1 ATE218345 T1 AT E218345T1
Authority
AT
Austria
Prior art keywords
represent
spinocerebellar degeneration
drugs
ococh3
hydrogen
Prior art date
Application number
AT95927966T
Other languages
English (en)
Inventor
Tetsuo Sakai
Yasunobu Antoku
Toyojiro Matsuishi
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of ATE218345T1 publication Critical patent/ATE218345T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT95927966T 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration ATE218345T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18468294 1994-08-05
PCT/JP1995/001550 WO1996003989A1 (en) 1994-08-05 1995-08-04 Remedy for spinocerebellar degeneration

Publications (1)

Publication Number Publication Date
ATE218345T1 true ATE218345T1 (de) 2002-06-15

Family

ID=16157531

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95927966T ATE218345T1 (de) 1994-08-05 1995-08-04 Arzneimittel gegen spinocerebellare degeneration

Country Status (6)

Country Link
US (1) US5753656A (de)
EP (1) EP0722731B1 (de)
AT (1) ATE218345T1 (de)
DE (1) DE69526918T2 (de)
ES (1) ES2177654T3 (de)
WO (1) WO1996003989A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418097A1 (de) 1994-05-24 1995-11-30 Cassella Ag Verwendung von Tetrahydropteridin-Derivaten als Hemmstoffe der NO-Synthase
DE69733308D1 (de) * 1996-07-31 2005-06-23 Cmic Co Aktivsauerstoffaufnehmer enthaltende pterinderivate
DE69725721T3 (de) † 1996-08-30 2007-10-31 Daiichi Asubio Pharma Co., Ltd. Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
JP4306825B2 (ja) 1998-02-27 2009-08-05 アスビオファーマ株式会社 インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
US7167844B1 (en) 1999-12-22 2007-01-23 Accenture Llp Electronic menu document creator in a virtual financial environment
US7610233B1 (en) 1999-12-22 2009-10-27 Accenture, Llp System, method and article of manufacture for initiation of bidding in a virtual trade financial environment
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
CA2479218A1 (en) * 2002-03-21 2003-10-02 Martin C. Hinz Serotonin and catecholamine system segment optimization technology
US20060110325A1 (en) * 2003-02-21 2006-05-25 Hinz Martin C Serotonin and catecholamine segment optimization technology
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
WO2005048926A2 (en) * 2003-11-13 2005-06-02 The General Hospital Corporation Methods for treating pain
PT3138566T (pt) 2003-11-17 2022-02-02 Biomarin Pharm Inc Tratamento de fenilcetonúria com bh4
US20080207624A1 (en) * 2004-05-11 2008-08-28 Osamu Sugita Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
CN101132776A (zh) * 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
US20100130500A1 (en) * 2004-12-08 2010-05-27 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
WO2007067570A1 (en) * 2005-12-05 2007-06-14 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of disease
WO2008089148A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiatry disorder with a bh4 derivative prodrug
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
KR20160065998A (ko) 2007-04-11 2016-06-09 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
AU2008347005B2 (en) 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
JP5066756B2 (ja) * 2010-04-22 2012-11-07 学校法人日本大学 脳機能障害予防・改善用の薬剤及び飲食物
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
RU2728717C1 (ru) * 2017-06-02 2020-07-30 ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. Средство для профилактики или лечения спиноцеребеллярной атаксии
MX2020002271A (es) 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
JP7778477B2 (ja) * 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー,インコーポレイテッド セピアプテリンの薬学的に許容される塩

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
JPS5976086A (ja) * 1982-09-20 1984-04-28 ザ ウエルカム フアウンデ−シヨン リミテツド プテリジン化合物
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE69229270D1 (en) * 1991-11-16 1999-07-01 Suntory Ltd Rezeptor für 6(r)-l-erythro-5,6,7,8-tetrahydrobiopterin

Also Published As

Publication number Publication date
DE69526918T2 (de) 2002-12-19
EP0722731A4 (de) 1998-03-04
US5753656A (en) 1998-05-19
WO1996003989A1 (en) 1996-02-15
DE69526918D1 (de) 2002-07-11
EP0722731B1 (de) 2002-06-05
EP0722731A1 (de) 1996-07-24
ES2177654T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
DE69526918D1 (de) Arzneimittel gegen spinocerebellare degeneration
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
DE69831868D1 (en) Antithrombosemittel
WO2001072728A3 (en) Novel piperazine derivatives
AU7278500A (en) Fungicides
AU1608692A (en) Amidinophenylalanine derivatives, a process for the preparation thereof, use thereof and agents containing these as anticoagulants
PT928788E (pt) Compostos farmaceuticamente activos
AU2003263878A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
HRP20020712A2 (en) Pharmaceutival compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
CA2336412A1 (en) Medicament for treatment of diabetes
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
HUT59139A (en) Process for producing tricyclic compounds and antimicrobial pharmaceutical compositions comprising same
FI924285A0 (fi) 4-desoxi-4 -epipodophyllotoxinderivat eller ett farmaceutiskt acceptabelt salt daerav.
EP1241158A4 (de) Verbindung mit hydroxycarbonyl-halogenalkyl-seitenkette
EP0754683A4 (de) Etherverbindungen, ihre verwendung und zwischenprodukte zu ihrer herstellung
WO2000046210A3 (en) New process for preparing pesticidal intermediates
IL166513A0 (en) Lamellarin derivatives and pharmaceutical compositions containing the same
EP0816366A4 (de) Imidazothiazolverbindungen
ATE241980T1 (de) Neue inhalationspräparate enthaltend cr 2039 (andolast)
MX9206930A (es) Nuevos compuestos
EP1026162A4 (de) Antirheumatika
FI911138A0 (fi) Ny substituerad aminfoerening och foerfarande foer dess framstaellning.
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
EP1136488A4 (de) Sf2809-i, ii, iii. vi, v und vi-verbindungen mit chymase-inhibierender wirkung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties